PMC:3586680 / 5001-6633
Annnotations
test3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T872 | 1523-1528 | Protein | denotes | CD133 |
| T871 | 1375-1380 | Protein | denotes | CD133 |
| T870 | 842-851 | Negative_regulation | denotes | knockdown |
| T869 | 836-841 | Protein | denotes | STAT3 |
| T868 | 823-832 | Negative_regulation | denotes | inhibitor |
| T867 | 817-822 | Protein | denotes | STAT3 |
| T866 | 638-642 | Protein | denotes | MGMT |
| T865 | 598-606 | Positive_regulation | denotes | increase |
| T864 | 532-537 | Protein | denotes | IFN-β |
| T863 | 518-530 | Protein | denotes | Interferon-β |
| T862 | 46-50 | Protein | denotes | MGMT |
| T835 | 1523-1528 | Protein | denotes | CD133 |
| T834 | 1375-1380 | Protein | denotes | CD133 |
| T833 | 836-841 | Protein | denotes | STAT3 |
| T832 | 817-822 | Protein | denotes | STAT3 |
| T831 | 638-642 | Protein | denotes | MGMT |
| T830 | 532-537 | Protein | denotes | IFN-β |
| T829 | 518-530 | Protein | denotes | Interferon-β |
| T828 | 46-50 | Protein | denotes | MGMT |
| R461 | T864 | T863 | equivalentTo | IFN-β,Interferon-β |
| R462 | T867 | T868 | themeOf | STAT3,inhibitor |
| R463 | T869 | T870 | themeOf | STAT3,knockdown |
testone
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T793 | 518-530 | Protein | denotes | Interferon-β |
| T792 | 46-50 | Protein | denotes | MGMT |
| T809 | 1412-1421 | Gene_expression | denotes | expressed |
| T808 | 852-863 | Negative_regulation | denotes | potentiates |
| T807 | 842-851 | Negative_regulation | denotes | knockdown |
| T806 | 823-832 | Negative_regulation | denotes | inhibitor |
| T805 | 598-606 | Positive_regulation | denotes | increase |
| T799 | 1523-1528 | Protein | denotes | CD133 |
| T798 | 1375-1380 | Protein | denotes | CD133 |
| T797 | 836-841 | Protein | denotes | STAT3 |
| T796 | 817-822 | Protein | denotes | STAT3 |
| T795 | 638-642 | Protein | denotes | MGMT |
| T794 | 532-537 | Protein | denotes | IFN-β |
| R450 | T793 | T805 | causeOf | Interferon-β,increase |
| R451 | T794 | T793 | equivalentTo | IFN-β,Interferon-β |
| R452 | T796 | T806 | themeOf | STAT3,inhibitor |
| R453 | T797 | T807 | themeOf | STAT3,knockdown |
| R454 | T798 | T809 | themeOf | CD133,expressed |
bionlp-st-ge-2016-test-tees
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2314 | 1523-1528 | Protein | denotes | CD133 |
| T2313 | 1381-1389 | Gene_expression | denotes | positive |
| T2312 | 1375-1380 | Protein | denotes | CD133 |
| T2311 | 823-832 | Negative_regulation | denotes | inhibitor |
| T2310 | 842-851 | Negative_regulation | denotes | knockdown |
| T2309 | 823-832 | Negative_regulation | denotes | inhibitor |
| T2308 | 836-841 | Protein | denotes | STAT3 |
| T2307 | 817-822 | Protein | denotes | STAT3 |
| T2306 | 769-774 | Protein | denotes | NF-κB |
| T2305 | 578-591 | Protein | denotes | valproic acid |
| T2304 | 638-642 | Protein | denotes | MGMT |
| T2303 | 593-596 | Protein | denotes | VAP |
| T2302 | 46-50 | Protein | denotes | MGMT |
| R1546 | T2307 | T2309 | themeOf | STAT3,inhibitor |
| R1547 | T2308 | T2310 | themeOf | STAT3,knockdown |
| R1548 | T2310 | T2311 | themeOf | knockdown,inhibitor |
| R1549 | T2312 | T2313 | themeOf | CD133,positive |
bionlp-st-ge-2016-spacy-parsed
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3530 | 1631-1632 | . | denotes | . |
| T3529 | 1620-1631 | VBN | denotes | established |
| T3528 | 1617-1619 | VB | denotes | be |
| T3527 | 1614-1616 | TO | denotes | to |
| T3526 | 1610-1613 | RB | denotes | yet |
| T3525 | 1606-1609 | VBZ | denotes | has |
| T3524 | 1597-1605 | NN | denotes | function |
| T3523 | 1586-1596 | JJ | denotes | biological |
| T3522 | 1582-1585 | PRP$ | denotes | its |
| T3521 | 1579-1581 | TO | denotes | to |
| T3520 | 1570-1578 | JJ | denotes | relative |
| T3519 | 1564-1569 | NNS | denotes | cells |
| T3518 | 1559-1563 | NN | denotes | stem |
| T3517 | 1552-1558 | NN | denotes | cancer |
| T3516 | 1545-1551 | NN | denotes | glioma |
| T3515 | 1541-1544 | IN | denotes | for |
| T3514 | 1534-1540 | NN | denotes | marker |
| T3513 | 1532-1533 | DT | denotes | a |
| T3512 | 1529-1531 | IN | denotes | as |
| T3511 | 1523-1528 | NNP | denotes | CD133 |
| T3510 | 1520-1522 | IN | denotes | of |
| T3509 | 1515-1519 | NN | denotes | role |
| T3508 | 1511-1514 | DT | denotes | the |
| T3507 | 1509-1510 | , | denotes | , |
| T3506 | 1502-1509 | RB | denotes | However |
| T3505 | 1500-1501 | . | denotes | . |
| T3504 | 1499-1500 | -RRB- | denotes | ) |
| T3503 | 1495-1499 | CD | denotes | 2012 |
| T3502 | 1493-1494 | , | denotes | , |
| T3501 | 1483-1493 | NNP | denotes | Pilkington |
| T3500 | 1479-1482 | CC | denotes | and |
| T3499 | 1471-1478 | NNP | denotes | Donovan |
| T3498 | 1470-1471 | -LRB- | denotes | ( |
| T3497 | 1464-1469 | NNS | denotes | cells |
| T3496 | 1459-1463 | NN | denotes | stem |
| T3495 | 1452-1458 | NN | denotes | cancer |
| T3494 | 1448-1451 | CC | denotes | and |
| T3493 | 1442-1447 | NNS | denotes | cells |
| T3492 | 1437-1441 | NN | denotes | stem |
| T3491 | 1430-1436 | JJ | denotes | normal |
| T3490 | 1425-1429 | DT | denotes | both |
| T3489 | 1422-1424 | IN | denotes | in |
| T3488 | 1412-1421 | VBN | denotes | expressed |
| T3487 | 1408-1411 | VBP | denotes | are |
| T3486 | 1402-1407 | NNS | denotes | cells |
| T3485 | 1397-1401 | NN | denotes | stem |
| T3484 | 1390-1396 | NN | denotes | cancer |
| T3483 | 1375-1389 | JJ | denotes | CD133-positive |
| T3482 | 1373-1374 | . | denotes | . |
| T3481 | 1372-1373 | -RRB- | denotes | ) |
| T3480 | 1368-1372 | CD | denotes | 2012 |
| T3479 | 1366-1367 | , | denotes | , |
| T3478 | 1363-1366 | FW | denotes | al. |
| T3477 | 1360-1362 | FW | denotes | et |
| T3476 | 1355-1359 | NNP | denotes | Chen |
| T3475 | 1353-1354 | : | denotes | ; |
| T3474 | 1349-1353 | CD | denotes | 2011 |
| T3473 | 1347-1348 | , | denotes | , |
| T3472 | 1344-1347 | FW | denotes | al. |
| T3471 | 1341-1343 | FW | denotes | et |
| T3470 | 1335-1340 | NNP | denotes | Beier |
| T3469 | 1334-1335 | -LRB- | denotes | ( |
| T3468 | 1326-1333 | VBN | denotes | thought |
| T3467 | 1315-1325 | RB | denotes | previously |
| T3466 | 1310-1314 | IN | denotes | than |
| T3465 | 1298-1309 | JJ | denotes | complicated |
| T3464 | 1293-1297 | RBR | denotes | more |
| T3463 | 1288-1292 | VBN | denotes | been |
| T3462 | 1284-1287 | VBZ | denotes | has |
| T3461 | 1278-1283 | NNS | denotes | drugs |
| T3460 | 1261-1277 | JJ | denotes | chemotherapeutic |
| T3459 | 1255-1260 | JJ | denotes | other |
| T3458 | 1251-1254 | CC | denotes | and |
| T3457 | 1247-1250 | NNP | denotes | TMZ |
| T3456 | 1242-1246 | IN | denotes | with |
| T3455 | 1232-1241 | NN | denotes | treatment |
| T3454 | 1227-1231 | IN | denotes | from |
| T3453 | 1218-1226 | NN | denotes | survival |
| T3452 | 1213-1217 | NN | denotes | cell |
| T3451 | 1208-1212 | NN | denotes | stem |
| T3450 | 1201-1207 | NN | denotes | cancer |
| T3449 | 1198-1200 | IN | denotes | of |
| T3448 | 1190-1197 | NN | denotes | concept |
| T3447 | 1186-1189 | DT | denotes | The |
| T3446 | 1184-1185 | . | denotes | . |
| T3445 | 1175-1184 | NN | denotes | treatment |
| T3444 | 1171-1174 | NNP | denotes | TMZ |
| T3443 | 1168-1170 | IN | denotes | in |
| T3442 | 1160-1167 | NN | denotes | failure |
| T3441 | 1157-1159 | TO | denotes | to |
| T3440 | 1153-1156 | NN | denotes | key |
| T3439 | 1149-1152 | DT | denotes | the |
| T3438 | 1140-1148 | RB | denotes | probably |
| T3437 | 1136-1139 | VBP | denotes | are |
| T3436 | 1130-1135 | NNS | denotes | cells |
| T3435 | 1125-1129 | NN | denotes | stem |
| T3434 | 1118-1124 | NNP | denotes | Cancer |
| T3433 | 1116-1117 | . | denotes | . |
| T3432 | 1115-1116 | -RRB- | denotes | ) |
| T3431 | 1111-1115 | CD | denotes | 2012 |
| T3430 | 1109-1110 | , | denotes | , |
| T3429 | 1106-1109 | FW | denotes | al. |
| T3428 | 1103-1105 | FW | denotes | et |
| T3427 | 1099-1102 | NNP | denotes | Sun |
| T3426 | 1098-1099 | -LRB- | denotes | ( |
| T3425 | 1093-1097 | NNS | denotes | GBMs |
| T3424 | 1090-1092 | IN | denotes | in |
| T3423 | 1079-1089 | NN | denotes | resistance |
| T3422 | 1075-1078 | NNP | denotes | TMZ |
| T3421 | 1067-1074 | VB | denotes | reverse |
| T3420 | 1064-1066 | TO | denotes | to |
| T3419 | 1055-1063 | VBN | denotes | utilized |
| T3418 | 1052-1054 | VB | denotes | be |
| T3417 | 1048-1051 | MD | denotes | can |
| T3416 | 1038-1047 | NN | denotes | hyperoxia |
| T3415 | 1030-1037 | VBN | denotes | Induced |
| T3414 | 1028-1029 | . | denotes | . |
| T3413 | 1018-1028 | NN | denotes | resistance |
| T3412 | 1014-1017 | NNP | denotes | TMZ |
| T3411 | 1011-1013 | IN | denotes | of |
| T3410 | 999-1010 | NN | denotes | development |
| T3409 | 995-998 | DT | denotes | the |
| T3408 | 990-994 | IN | denotes | with |
| T3407 | 979-989 | VBN | denotes | associated |
| T3406 | 976-978 | VB | denotes | be |
| T3405 | 972-975 | MD | denotes | may |
| T3404 | 968-971 | CC | denotes | and |
| T3403 | 963-967 | NNS | denotes | GBMs |
| T3402 | 960-962 | IN | denotes | in |
| T3401 | 953-959 | JJ | denotes | common |
| T3400 | 950-952 | VBZ | denotes | is |
| T3399 | 942-949 | NN | denotes | hypoxia |
| T3398 | 929-941 | NNP | denotes | Intratumoral |
| T3397 | 927-928 | . | denotes | . |
| T3396 | 926-927 | -RRB- | denotes | ) |
| T3395 | 922-926 | CD | denotes | 2012 |
| T3394 | 920-921 | , | denotes | , |
| T3393 | 917-920 | FW | denotes | al. |
| T3392 | 914-916 | FW | denotes | et |
| T3391 | 906-913 | NNP | denotes | Kohsaka |
| T3390 | 905-906 | -LRB- | denotes | ( |
| T3389 | 899-904 | NNS | denotes | lines |
| T3388 | 894-898 | NN | denotes | cell |
| T3387 | 890-893 | NNP | denotes | GBM |
| T3386 | 880-889 | JJ | denotes | resistant |
| T3385 | 877-879 | IN | denotes | in |
| T3384 | 868-876 | NN | denotes | efficacy |
| T3383 | 864-867 | NNP | denotes | TMZ |
| T3382 | 852-863 | NNS | denotes | potentiates |
| T3381 | 842-851 | JJ | denotes | knockdown |
| T3380 | 836-841 | CD | denotes | STAT3 |
| T3379 | 833-835 | CC | denotes | or |
| T3378 | 823-832 | NN | denotes | inhibitor |
| T3377 | 817-822 | CD | denotes | STAT3 |
| T3376 | 815-816 | . | denotes | . |
| T3375 | 814-815 | -RRB- | denotes | ) |
| T3374 | 810-814 | CD | denotes | 2012 |
| T3373 | 808-809 | , | denotes | , |
| T3372 | 805-808 | FW | denotes | al. |
| T3371 | 802-804 | FW | denotes | et |
| T3370 | 796-801 | NNP | denotes | Huang |
| T3369 | 795-796 | -LRB- | denotes | ( |
| T3368 | 785-794 | NN | denotes | mechanism |
| T3367 | 769-784 | JJ | denotes | NF-κB-dependent |
| T3366 | 766-768 | DT | denotes | an |
| T3365 | 762-765 | IN | denotes | via |
| T3364 | 751-761 | NN | denotes | resistance |
| T3363 | 747-750 | NNP | denotes | TMZ |
| T3362 | 738-746 | VBZ | denotes | reverses |
| T3361 | 736-737 | , | denotes | , |
| T3332 | 578-586 | JJ | denotes | valproic |
| T3331 | 574-577 | CC | denotes | and |
| T3330 | 572-573 | , | denotes | , |
| T3329 | 561-572 | NN | denotes | resveratrol |
| T3328 | 559-560 | , | denotes | , |
| T3327 | 558-559 | -RRB- | denotes | ) |
| T3326 | 555-558 | NNP | denotes | LEV |
| T3325 | 554-555 | -LRB- | denotes | ( |
| T3324 | 540-553 | NN | denotes | levetiracetam |
| T3323 | 538-539 | , | denotes | , |
| T3322 | 537-538 | -RRB- | denotes | ) |
| T3321 | 532-537 | NNP | denotes | IFN-β |
| T3320 | 531-532 | -LRB- | denotes | ( |
| T3319 | 518-530 | NNP | denotes | Interferon-β |
| T3318 | 516-517 | . | denotes | . |
| T3317 | 515-516 | -RRB- | denotes | ) |
| T3316 | 511-515 | CD | denotes | 2011 |
| T3315 | 509-510 | , | denotes | , |
| T3314 | 506-509 | FW | denotes | al. |
| T3313 | 503-505 | FW | denotes | et |
| T3312 | 494-502 | NNP | denotes | Goellner |
| T3311 | 493-494 | -LRB- | denotes | ( |
| T3310 | 489-492 | NNP | denotes | GBM |
| T3309 | 479-488 | JJ | denotes | recurrent |
| T3308 | 475-478 | CC | denotes | and |
| T3307 | 465-474 | JJ | denotes | resistant |
| T3306 | 460-464 | IN | denotes | with |
| T3305 | 451-459 | NNS | denotes | patients |
| T3304 | 448-450 | IN | denotes | in |
| T3303 | 437-447 | NN | denotes | resistance |
| T3302 | 433-436 | NNP | denotes | TMZ |
| T3301 | 425-432 | VB | denotes | reverse |
| T3300 | 421-424 | MD | denotes | may |
| T3299 | 408-420 | NN | denotes | biosynthesis |
| T3298 | 406-407 | -RRB- | denotes | ) |
| T3297 | 405-406 | VBN | denotes | + |
| T3296 | 404-405 | -LRB- | denotes | ( |
| T3295 | 401-404 | NNP | denotes | NAD |
| T3294 | 397-400 | CC | denotes | and |
| T3293 | 390-396 | NN | denotes | repair |
| T3292 | 381-389 | NN | denotes | excision |
| T3291 | 376-380 | NN | denotes | base |
| T3290 | 373-375 | IN | denotes | of |
| T3289 | 363-372 | VBG | denotes | targeting |
| T3288 | 358-362 | JJ | denotes | Dual |
| T3287 | 356-357 | . | denotes | . |
| T3286 | 355-356 | -RRB- | denotes | ) |
| T3285 | 350-355 | JJ | denotes | 2012b |
| T3284 | 348-349 | , | denotes | , |
| T3283 | 345-348 | FW | denotes | al. |
| T3282 | 342-344 | FW | denotes | et |
| T3281 | 336-341 | NNP | denotes | Zhang |
| T3280 | 334-335 | : | denotes | ; |
| T3279 | 330-334 | CD | denotes | 2011 |
| T3278 | 328-329 | , | denotes | , |
| T3277 | 325-328 | FW | denotes | al. |
| T3276 | 322-324 | FW | denotes | et |
| T3275 | 313-321 | NNP | denotes | Goellner |
| T3274 | 312-313 | -LRB- | denotes | ( |
| T3273 | 302-311 | VBN | denotes | tolerated |
| T3272 | 299-301 | CC | denotes | or |
| T3271 | 290-298 | VBN | denotes | repaired |
| T3270 | 286-289 | VBP | denotes | are |
| T3269 | 278-285 | NNS | denotes | adducts |
| T3268 | 261-277 | JJ | denotes | O6-methylguanine |
| T3267 | 256-260 | WRB | denotes | when |
| T3266 | 243-255 | RB | denotes | particularly |
| T3265 | 230-242 | NN | denotes | cytotoxicity |
| T3264 | 226-229 | NNP | denotes | TMZ |
| T3263 | 223-225 | TO | denotes | to |
| T3262 | 209-222 | RB | denotes | significantly |
| T3261 | 197-208 | VBZ | denotes | contributes |
| T3260 | 190-196 | NN | denotes | repair |
| T3259 | 181-189 | NN | denotes | excision |
| T3258 | 176-180 | NN | denotes | base |
| T3257 | 173-175 | IN | denotes | of |
| T3256 | 152-172 | NN | denotes | Methoxyamine-blocker |
| T3255 | 150-151 | . | denotes | . |
| T3254 | 149-150 | -RRB- | denotes | ) |
| T3253 | 144-149 | JJ | denotes | 2012b |
| T3252 | 142-143 | , | denotes | , |
| T3251 | 139-142 | FW | denotes | al. |
| T3250 | 136-138 | FW | denotes | et |
| T3249 | 130-135 | NNP | denotes | Zhang |
| T3248 | 129-130 | -LRB- | denotes | ( |
| T3247 | 125-128 | NNP | denotes | TMZ |
| T3246 | 122-124 | TO | denotes | to |
| T3245 | 115-121 | NNS | denotes | tumors |
| T3244 | 105-114 | VB | denotes | sensitize |
| T3243 | 102-104 | TO | denotes | to |
| T3242 | 90-101 | NN | denotes | lomeguatrib |
| T3241 | 86-89 | CC | denotes | and |
| T3240 | 69-85 | NN | denotes | O6-benzylguanine |
| T3239 | 67-68 | , | denotes | , |
| T3238 | 51-67 | NNS | denotes | pseudosubstrates |
| T3237 | 46-50 | NNP | denotes | MGMT |
| T3236 | 43-45 | IN | denotes | by |
| T3235 | 34-42 | VBN | denotes | achieved |
| T3234 | 31-33 | VB | denotes | be |
| T3233 | 27-30 | MD | denotes | may |
| T3232 | 16-26 | NN | denotes | resistance |
| T3231 | 12-15 | NNP | denotes | TMZ |
| T3230 | 9-11 | IN | denotes | of |
| T3229 | 0-8 | NN | denotes | Reversal |
| T3360 | 726-736 | NN | denotes | polyphenol |
| T3359 | 718-725 | JJ | denotes | natural |
| T3358 | 716-717 | DT | denotes | a |
| T3357 | 714-715 | , | denotes | , |
| T3356 | 703-714 | NNP | denotes | Resveratrol |
| T3355 | 701-702 | . | denotes | . |
| T3354 | 700-701 | -RRB- | denotes | ) |
| T3353 | 696-700 | CD | denotes | 2012 |
| T3352 | 694-695 | , | denotes | , |
| T3351 | 691-694 | FW | denotes | al. |
| T3350 | 688-690 | FW | denotes | et |
| T3349 | 681-687 | NNP | denotes | Nakada |
| T3348 | 680-681 | -LRB- | denotes | ( |
| T3347 | 669-679 | NNS | denotes | mechanisms |
| T3346 | 657-668 | JJ | denotes | independent |
| T3345 | 656-657 | : | denotes | - |
| T3344 | 653-655 | CC | denotes | or |
| T3343 | 638-652 | NNP | denotes | MGMT-dependent |
| T3342 | 630-637 | IN | denotes | through |
| T3341 | 626-629 | NNP | denotes | TMZ |
| T3340 | 623-625 | IN | denotes | of |
| T3339 | 611-622 | NN | denotes | sensitivity |
| T3338 | 607-610 | DT | denotes | the |
| T3337 | 598-606 | VB | denotes | increase |
| T3336 | 596-597 | -RRB- | denotes | ) |
| T3335 | 593-596 | NNP | denotes | VAP |
| T3334 | 592-593 | -LRB- | denotes | ( |
| T3333 | 587-591 | NN | denotes | acid |
| R2256 | T3229 | T3235 | nsubjpass | Reversal,achieved |
| R2257 | T3230 | T3229 | prep | of,Reversal |
| R2258 | T3231 | T3230 | pobj | TMZ,of |
| R2259 | T3232 | T3235 | nsubjpass | resistance,achieved |
| R2260 | T3233 | T3235 | aux | may,achieved |
| R2262 | T3234 | T3235 | auxpass | be,achieved |
| R2263 | T3235 | T3235 | ROOT | achieved,achieved |
| R2264 | T3236 | T3235 | agent | by,achieved |
| R2266 | T3237 | T3238 | compound | MGMT,pseudosubstrates |
| R2267 | T3238 | T3236 | pobj | pseudosubstrates,by |
| R2268 | T3239 | T3238 | punct | ",",pseudosubstrates |
| R2270 | T3240 | T3238 | conj | O6-benzylguanine,pseudosubstrates |
| R2271 | T3241 | T3240 | cc | and,O6-benzylguanine |
| R2273 | T3242 | T3240 | conj | lomeguatrib,O6-benzylguanine |
| R2274 | T3243 | T3244 | aux | to,sensitize |
| R2275 | T3244 | T3235 | xcomp | sensitize,achieved |
| R2276 | T3245 | T3244 | dobj | tumors,sensitize |
| R2278 | T3246 | T3244 | prep | to,sensitize |
| R2280 | T3247 | T3246 | pobj | TMZ,to |
| R2283 | T3248 | T3251 | punct | (,al. |
| R2286 | T3249 | T3251 | compound | Zhang,al. |
| R2287 | T3250 | T3251 | nmod | et,al. |
| R2289 | T3251 | T3246 | parataxis | al.,to |
| R2290 | T3252 | T3251 | punct | ",",al. |
| R2291 | T3253 | T3251 | amod | 2012b,al. |
| R2293 | T3254 | T3251 | punct | ),al. |
| R2294 | T3255 | T3235 | punct | .,achieved |
| R2297 | T3256 | T3261 | nsubj | Methoxyamine-blocker,contributes |
| R2299 | T3257 | T3256 | prep | of,Methoxyamine-blocker |
| R2300 | T3258 | T3260 | compound | base,repair |
| R2301 | T3259 | T3260 | compound | excision,repair |
| R2303 | T3260 | T3257 | pobj | repair,of |
| R2304 | T3261 | T3261 | ROOT | contributes,contributes |
| R2305 | T3262 | T3261 | advmod | significantly,contributes |
| R2307 | T3263 | T3261 | prep | to,contributes |
| R2308 | T3264 | T3265 | compound | TMZ,cytotoxicity |
| R2309 | T3265 | T3263 | pobj | cytotoxicity,to |
| R2310 | T3266 | T3271 | advmod | particularly,repaired |
| R2311 | T3267 | T3271 | advmod | when,repaired |
| R2312 | T3268 | T3269 | amod | O6-methylguanine,adducts |
| R2314 | T3269 | T3271 | nsubjpass | adducts,repaired |
| R2315 | T3270 | T3271 | auxpass | are,repaired |
| R2316 | T3271 | T3261 | advcl | repaired,contributes |
| R2318 | T3272 | T3271 | cc | or,repaired |
| R2319 | T3273 | T3271 | conj | tolerated,repaired |
| R2320 | T3274 | T3283 | punct | (,al. |
| R2321 | T3275 | T3277 | nmod | Goellner,al. |
| R2323 | T3276 | T3277 | nmod | et,al. |
| R2324 | T3277 | T3283 | ccomp | al.,al. |
| R2326 | T3278 | T3277 | punct | ",",al. |
| R2327 | T3279 | T3277 | npadvmod | 2011,al. |
| R2328 | T3280 | T3283 | punct | ;,al. |
| R2330 | T3281 | T3283 | compound | Zhang,al. |
| R2331 | T3282 | T3283 | nmod | et,al. |
| R2332 | T3283 | T3283 | ROOT | al.,al. |
| R2334 | T3284 | T3285 | punct | ",",2012b |
| R2335 | T3285 | T3283 | amod | 2012b,al. |
| R2336 | T3286 | T3285 | punct | ),2012b |
| R2338 | T3287 | T3261 | punct | .,contributes |
| R2340 | T3288 | T3289 | amod | Dual,targeting |
| R2343 | T3289 | T3301 | nsubj | targeting,reverse |
| R2344 | T3290 | T3289 | prep | of,targeting |
| R2345 | T3291 | T3293 | compound | base,repair |
| R2347 | T3292 | T3293 | compound | excision,repair |
| R2348 | T3293 | T3290 | pobj | repair,of |
| R2350 | T3294 | T3293 | cc | and,repair |
| R2351 | T3295 | T3299 | nmod | NAD,biosynthesis |
| R2352 | T3296 | T3297 | punct | (,+ |
| R2354 | T3297 | T3295 | parataxis | +,NAD |
| R2355 | T3298 | T3299 | punct | ),biosynthesis |
| R2356 | T3299 | T3293 | conj | biosynthesis,repair |
| R2357 | T3300 | T3301 | aux | may,reverse |
| R2359 | T3301 | T3301 | ROOT | reverse,reverse |
| R2360 | T3302 | T3303 | compound | TMZ,resistance |
| R2361 | T3303 | T3301 | dobj | resistance,reverse |
| R2362 | T3304 | T3301 | prep | in,reverse |
| R2363 | T3305 | T3304 | pobj | patients,in |
| R2364 | T3306 | T3305 | prep | with,patients |
| R2366 | T3307 | T3310 | amod | resistant,GBM |
| R2367 | T3308 | T3307 | cc | and,resistant |
| R2368 | T3309 | T3307 | conj | recurrent,resistant |
| R2370 | T3310 | T3306 | pobj | GBM,with |
| R2371 | T3311 | T3310 | punct | (,GBM |
| R2372 | T3312 | T3314 | nmod | Goellner,al. |
| R2374 | T3313 | T3314 | nmod | et,al. |
| R2375 | T3314 | T3301 | dep | al.,reverse |
| R2378 | T3315 | T3314 | punct | ",",al. |
| R2380 | T3316 | T3314 | npadvmod | 2011,al. |
| R2381 | T3317 | T3314 | punct | ),al. |
| R2382 | T3318 | T3301 | punct | .,reverse |
| R2383 | T3319 | T3337 | nsubj | Interferon-β,increase |
| R2385 | T3320 | T3321 | punct | (,IFN-β |
| R2386 | T3321 | T3319 | appos | IFN-β,Interferon-β |
| R2387 | T3322 | T3321 | punct | ),IFN-β |
| R2389 | T3323 | T3319 | punct | ",",Interferon-β |
| R2390 | T3324 | T3319 | appos | levetiracetam,Interferon-β |
| R2391 | T3325 | T3326 | punct | (,LEV |
| R2393 | T3326 | T3324 | appos | LEV,levetiracetam |
| R2394 | T3327 | T3326 | punct | ),LEV |
| R2395 | T3328 | T3324 | punct | ",",levetiracetam |
| R2397 | T3329 | T3324 | conj | resveratrol,levetiracetam |
| R2398 | T3330 | T3329 | punct | ",",resveratrol |
| R2399 | T3331 | T3329 | cc | and,resveratrol |
| R2401 | T3332 | T3333 | amod | valproic,acid |
| R2402 | T3333 | T3329 | conj | acid,resveratrol |
| R2403 | T3334 | T3333 | punct | (,acid |
| R2404 | T3335 | T3337 | nsubj | VAP,increase |
| R2406 | T3336 | T3337 | punct | ),increase |
| R2407 | T3337 | T3337 | ROOT | increase,increase |
| R2409 | T3338 | T3339 | det | the,sensitivity |
| R2410 | T3339 | T3337 | dobj | sensitivity,increase |
| R2411 | T3340 | T3339 | prep | of,sensitivity |
| R2412 | T3341 | T3340 | pobj | TMZ,of |
| R2413 | T3342 | T3337 | prep | through,increase |
| R2415 | T3343 | T3342 | pobj | MGMT-dependent,through |
| R2416 | T3344 | T3343 | cc | or,MGMT-dependent |
| R2417 | T3345 | T3346 | punct | -,independent |
| R2419 | T3443 | T3442 | prep | in,failure |
| R2420 | T3346 | T3347 | amod | independent,mechanisms |
| R2421 | T3347 | T3343 | conj | mechanisms,MGMT-dependent |
| R2422 | T3348 | T3347 | punct | (,mechanisms |
| R2423 | T3444 | T3445 | compound | TMZ,treatment |
| R2424 | T3349 | T3351 | compound | Nakada,al. |
| R2425 | T3350 | T3351 | nmod | et,al. |
| R2426 | T3351 | T3347 | appos | al.,mechanisms |
| R2427 | T3445 | T3443 | pobj | treatment,in |
| R2428 | T3352 | T3351 | punct | ",",al. |
| R2429 | T3353 | T3351 | npadvmod | 2012,al. |
| R2430 | T3446 | T3437 | punct | .,are |
| R2431 | T3354 | T3347 | punct | ),mechanisms |
| R2432 | T3447 | T3448 | det | The,concept |
| R2433 | T3355 | T3337 | punct | .,increase |
| R2434 | T3356 | T3362 | nsubj | Resveratrol,reverses |
| R2435 | T3357 | T3356 | punct | ",",Resveratrol |
| R2436 | T3448 | T3478 | nsubjpass | concept,al. |
| R2437 | T3358 | T3360 | det | a,polyphenol |
| R2438 | T3359 | T3360 | amod | natural,polyphenol |
| R2439 | T3360 | T3356 | appos | polyphenol,Resveratrol |
| R2440 | T3361 | T3356 | punct | ",",Resveratrol |
| R2441 | T3449 | T3448 | prep | of,concept |
| R2442 | T3362 | T3362 | ROOT | reverses,reverses |
| R2443 | T3363 | T3364 | compound | TMZ,resistance |
| R2444 | T3450 | T3452 | compound | cancer,cell |
| R2445 | T3364 | T3362 | dobj | resistance,reverses |
| R2446 | T3365 | T3362 | prep | via,reverses |
| R2447 | T3366 | T3368 | det | an,mechanism |
| R2448 | T3451 | T3452 | compound | stem,cell |
| R2449 | T3367 | T3368 | amod | NF-κB-dependent,mechanism |
| R2450 | T3368 | T3365 | pobj | mechanism,via |
| R2451 | T3369 | T3368 | punct | (,mechanism |
| R2452 | T3452 | T3453 | compound | cell,survival |
| R2453 | T3370 | T3372 | compound | Huang,al. |
| R2454 | T3371 | T3372 | nmod | et,al. |
| R2455 | T3453 | T3449 | pobj | survival,of |
| R2456 | T3372 | T3368 | appos | al.,mechanism |
| R2457 | T3373 | T3372 | punct | ",",al. |
| R2458 | T3374 | T3372 | npadvmod | 2012,al. |
| R2459 | T3454 | T3448 | prep | from,concept |
| R2460 | T3375 | T3368 | punct | ),mechanism |
| R2461 | T3376 | T3362 | punct | .,reverses |
| R2462 | T3377 | T3378 | nummod | STAT3,inhibitor |
| R2463 | T3378 | T3384 | nmod | inhibitor,efficacy |
| R2464 | T3379 | T3378 | cc | or,inhibitor |
| R2465 | T3380 | T3382 | nummod | STAT3,potentiates |
| R2466 | T3381 | T3382 | amod | knockdown,potentiates |
| R2467 | T3455 | T3454 | pobj | treatment,from |
| R2468 | T3382 | T3378 | conj | potentiates,inhibitor |
| R2469 | T3383 | T3384 | compound | TMZ,efficacy |
| R2470 | T3384 | T3384 | ROOT | efficacy,efficacy |
| R2471 | T3456 | T3448 | prep | with,concept |
| R2472 | T3385 | T3384 | prep | in,efficacy |
| R2473 | T3386 | T3389 | amod | resistant,lines |
| R2474 | T3457 | T3456 | pobj | TMZ,with |
| R2475 | T3387 | T3389 | nmod | GBM,lines |
| R2476 | T3388 | T3389 | compound | cell,lines |
| R2477 | T3389 | T3385 | pobj | lines,in |
| R2478 | T3458 | T3457 | cc | and,TMZ |
| R2479 | T3390 | T3389 | punct | (,lines |
| R2480 | T3391 | T3393 | compound | Kohsaka,al. |
| R2481 | T3392 | T3393 | nmod | et,al. |
| R2482 | T3459 | T3461 | amod | other,drugs |
| R2483 | T3393 | T3389 | appos | al.,lines |
| R2484 | T3460 | T3461 | amod | chemotherapeutic,drugs |
| R2485 | T3394 | T3393 | punct | ",",al. |
| R2486 | T3461 | T3457 | conj | drugs,TMZ |
| R2487 | T3395 | T3393 | npadvmod | 2012,al. |
| R2488 | T3396 | T3389 | punct | ),lines |
| R2489 | T3462 | T3463 | aux | has,been |
| R2490 | T3397 | T3384 | punct | .,efficacy |
| R2491 | T3398 | T3399 | compound | Intratumoral,hypoxia |
| R2492 | T3399 | T3400 | nsubj | hypoxia,is |
| R2493 | T3463 | T3478 | auxpass | been,al. |
| R2494 | T3400 | T3400 | ROOT | is,is |
| R2495 | T3401 | T3400 | acomp | common,is |
| R2496 | T3464 | T3465 | advmod | more,complicated |
| R2497 | T3402 | T3400 | prep | in,is |
| R2498 | T3403 | T3402 | pobj | GBMs,in |
| R2499 | T3465 | T3478 | ccomp | complicated,al. |
| R2500 | T3404 | T3400 | cc | and,is |
| R2501 | T3405 | T3407 | aux | may,associated |
| R2502 | T3406 | T3407 | auxpass | be,associated |
| R2503 | T3466 | T3468 | mark | than,thought |
| R2504 | T3407 | T3400 | conj | associated,is |
| R2505 | T3408 | T3407 | prep | with,associated |
| R2506 | T3409 | T3410 | det | the,development |
| R2507 | T3467 | T3468 | advmod | previously,thought |
| R2508 | T3410 | T3408 | pobj | development,with |
| R2509 | T3411 | T3410 | prep | of,development |
| R2510 | T3412 | T3413 | compound | TMZ,resistance |
| R2511 | T3413 | T3411 | pobj | resistance,of |
| R2512 | T3414 | T3400 | punct | .,is |
| R2513 | T3415 | T3416 | amod | Induced,hyperoxia |
| R2514 | T3468 | T3465 | advcl | thought,complicated |
| R2515 | T3416 | T3419 | nsubjpass | hyperoxia,utilized |
| R2516 | T3417 | T3419 | aux | can,utilized |
| R2517 | T3418 | T3419 | auxpass | be,utilized |
| R2518 | T3419 | T3419 | ROOT | utilized,utilized |
| R2519 | T3469 | T3465 | punct | (,complicated |
| R2520 | T3420 | T3421 | aux | to,reverse |
| R2521 | T3421 | T3419 | xcomp | reverse,utilized |
| R2522 | T3422 | T3423 | compound | TMZ,resistance |
| R2523 | T3470 | T3472 | nmod | Beier,al. |
| R2524 | T3423 | T3421 | dobj | resistance,reverse |
| R2525 | T3424 | T3421 | prep | in,reverse |
| R2526 | T3425 | T3424 | pobj | GBMs,in |
| R2527 | T3471 | T3472 | nmod | et,al. |
| R2528 | T3472 | T3465 | punct | al.,complicated |
| R2529 | T3426 | T3429 | punct | (,al. |
| R2530 | T3473 | T3472 | punct | ",",al. |
| R2531 | T3427 | T3429 | nmod | Sun,al. |
| R2532 | T3428 | T3429 | nmod | et,al. |
| R2533 | T3429 | T3419 | parataxis | al.,utilized |
| R2534 | T3474 | T3472 | npadvmod | 2011,al. |
| R2535 | T3430 | T3429 | punct | ",",al. |
| R2536 | T3431 | T3429 | npadvmod | 2012,al. |
| R2537 | T3475 | T3478 | punct | ;,al. |
| R2538 | T3432 | T3429 | punct | ),al. |
| R2539 | T3433 | T3419 | punct | .,utilized |
| R2540 | T3434 | T3436 | compound | Cancer,cells |
| R2541 | T3476 | T3478 | compound | Chen,al. |
| R2542 | T3435 | T3436 | compound | stem,cells |
| R2543 | T3436 | T3437 | nsubj | cells,are |
| R2544 | T3437 | T3437 | ROOT | are,are |
| R2545 | T3477 | T3478 | compound | et,al. |
| R2546 | T3478 | T3478 | ROOT | al.,al. |
| R2547 | T3479 | T3478 | punct | ",",al. |
| R2548 | T3438 | T3437 | advmod | probably,are |
| R2549 | T3439 | T3440 | det | the,key |
| R2550 | T3480 | T3478 | npadvmod | 2012,al. |
| R2551 | T3440 | T3437 | attr | key,are |
| R2552 | T3441 | T3440 | prep | to,key |
| R2553 | T3481 | T3478 | punct | ),al. |
| R2554 | T3442 | T3441 | pobj | failure,to |
| R2555 | T3482 | T3478 | punct | .,al. |
| R2556 | T3483 | T3486 | amod | CD133-positive,cells |
| R2557 | T3484 | T3485 | compound | cancer,stem |
| R2558 | T3485 | T3486 | compound | stem,cells |
| R2559 | T3488 | T3488 | ROOT | expressed,expressed |
| R2560 | T3489 | T3488 | prep | in,expressed |
| R2561 | T3490 | T3493 | det | both,cells |
| R2562 | T3491 | T3493 | amod | normal,cells |
| R2563 | T3486 | T3488 | nsubjpass | cells,expressed |
| R2564 | T3492 | T3493 | compound | stem,cells |
| R2565 | T3493 | T3489 | pobj | cells,in |
| R2566 | T3494 | T3493 | cc | and,cells |
| R2567 | T3495 | T3496 | compound | cancer,stem |
| R2568 | T3487 | T3488 | auxpass | are,expressed |
| R2569 | T3496 | T3497 | compound | stem,cells |
| R2570 | T3497 | T3493 | conj | cells,cells |
| R2571 | T3498 | T3488 | punct | (,expressed |
| R2572 | T3499 | T3488 | dep | Donovan,expressed |
| R2573 | T3500 | T3499 | cc | and,Donovan |
| R2574 | T3501 | T3499 | conj | Pilkington,Donovan |
| R2575 | T3502 | T3501 | punct | ",",Pilkington |
| R2576 | T3503 | T3501 | npadvmod | 2012,Pilkington |
| R2577 | T3504 | T3501 | punct | ),Pilkington |
| R2578 | T3505 | T3488 | punct | .,expressed |
| R2579 | T3506 | T3529 | advmod | However,established |
| R2580 | T3507 | T3529 | punct | ",",established |
| R2581 | T3508 | T3509 | det | the,role |
| R2582 | T3509 | T3529 | nsubjpass | role,established |
| R2583 | T3510 | T3509 | prep | of,role |
| R2584 | T3511 | T3510 | pobj | CD133,of |
| R2585 | T3512 | T3509 | prep | as,role |
| R2586 | T3513 | T3514 | det | a,marker |
| R2587 | T3514 | T3512 | pobj | marker,as |
| R2588 | T3515 | T3514 | prep | for,marker |
| R2589 | T3516 | T3519 | amod | glioma,cells |
| R2590 | T3517 | T3518 | compound | cancer,stem |
| R2591 | T3518 | T3519 | compound | stem,cells |
| R2592 | T3519 | T3515 | pobj | cells,for |
| R2593 | T3520 | T3519 | amod | relative,cells |
| R2594 | T3521 | T3520 | prep | to,relative |
| R2595 | T3522 | T3524 | poss | its,function |
| R2596 | T3523 | T3524 | amod | biological,function |
| R2597 | T3524 | T3521 | pobj | function,to |
| R2598 | T3525 | T3529 | aux | has,established |
| R2599 | T3526 | T3529 | advmod | yet,established |
| R2600 | T3527 | T3529 | aux | to,established |
| R2601 | T3528 | T3529 | auxpass | be,established |
| R2602 | T3529 | T3529 | ROOT | established,established |
| R2603 | T3530 | T3529 | punct | .,established |
bionlp-st-ge-2016-test-ihmc
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2491 | 1255-1283 | Entity | denotes | other chemotherapeutic drugs |
| T2489 | 1014-1017 | Entity | denotes | TMZ |
| T2484 | 261-277 | Entity | denotes | O6-methylguanine |
| T2483 | 561-573 | Entity | denotes | resveratrol, |
| T2479 | 1381-1407 | Entity | denotes | positive cancer stem cells |
| T2478 | 518-553 | Entity | denotes | Interferon-β (IFN-β), levetiracetam |
| T2473 | 46-50 | Protein | denotes | MGMT |
| T2472 | 90-101 | Entity | denotes | lomeguatrib |
| T2471 | 261-285 | Entity | denotes | O6-methylguanine adducts |
| T2470 | 593-596 | Protein | denotes | VAP |
| T2469 | 626-629 | Entity | denotes | TMZ |
| T2459 | 1247-1250 | Entity | denotes | TMZ |
| T2457 | 1520-1528 | Protein | denotes | of CD133 |
| T2455 | 864-867 | Entity | denotes | TMZ |
| T2454 | 836-841 | Protein | denotes | STAT3 |
| T2447 | 46-67 | Entity | denotes | MGMT pseudosubstrates |
| T2441 | 823-832 | Entity | denotes | inhibitor |
| T2440 | 401-404 | Entity | denotes | NAD |
| T2436 | 12-15 | Entity | denotes | TMZ |
| T2434 | 1171-1174 | Entity | denotes | TMZ |
| T2430 | 578-597 | Entity | denotes | valproic acid (VAP) |
| T2427 | 703-737 | Entity | denotes | Resveratrol, a natural polyphenol, |
| T2425 | 226-229 | Entity | denotes | TMZ |
| T2424 | 1099-1102 | Protein | denotes | Sun |
| T2422 | 817-851 | Protein | denotes | STAT3 inhibitor or STAT3 knockdown |
| T2418 | 261-277 | Entity | denotes | O6-methylguanine |
| T2415 | 264-277 | Entity | denotes | methylguanine |
| T2413 | 1075-1078 | Entity | denotes | TMZ |
| T2408 | 1375-1380 | Protein | denotes | CD133 |
| T2404 | 747-750 | Entity | denotes | TMZ |
| T2402 | 433-436 | Entity | denotes | TMZ |
| T2398 | 769-784 | Protein | denotes | NF-κB-dependent |
| T2396 | 716-736 | Entity | denotes | a natural polyphenol |
| T2394 | 122-128 | Entity | denotes | to TMZ |
| T2393 | 1452-1469 | Entity | denotes | cancer stem cells |
| T2387 | 1545-1569 | Entity | denotes | glioma cancer stem cells |
| T2383 | 1118-1135 | Entity | denotes | Cancer stem cells |
| T2382 | 1208-1217 | Entity | denotes | stem cell |
| T2380 | 1582-1605 | Entity | denotes | its biological function |
| T2379 | 152-196 | Entity | denotes | Methoxyamine-blocker of base excision repair |
| T2376 | 69-85 | Entity | denotes | O6-benzylguanine |
| T2374 | 638-652 | Protein | denotes | MGMT-dependent |
| T2369 | 1430-1447 | Entity | denotes | normal stem cells |
| T2367 | 518-539 | Protein | denotes | Interferon-β (IFN-β), |
| T2361 | 532-537 | Protein | denotes | IFN-β |
DLUT931
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2198 | 1381-1389 | Gene_expression | denotes | positive |
| T2197 | 823-832 | Negative_regulation | denotes | inhibitor |
| T2196 | 842-851 | Negative_regulation | denotes | knockdown |
| T2183 | 1523-1528 | Protein | denotes | CD133 |
| T2182 | 1375-1380 | Protein | denotes | CD133 |
| T2181 | 836-841 | Protein | denotes | STAT3 |
| T2180 | 817-822 | Protein | denotes | STAT3 |
| T2179 | 638-642 | Protein | denotes | MGMT |
| T2178 | 532-537 | Protein | denotes | IFN-β |
| T2177 | 518-530 | Protein | denotes | Interferon-β |
| T2176 | 46-50 | Protein | denotes | MGMT |
| R1499 | T2180 | T2197 | themeOf | STAT3,inhibitor |
| R1500 | T2181 | T2196 | themeOf | STAT3,knockdown |
| R1501 | T2182 | T2198 | themeOf | CD133,positive |
| R1508 | T2196 | T2197 | causeOf | knockdown,inhibitor |
BioNLP16_Messiy
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2259 | 1523-1528 | Protein | denotes | CD133 |
| T2258 | 1375-1380 | Protein | denotes | CD133 |
| T2257 | 836-841 | Protein | denotes | STAT3 |
| T2256 | 817-822 | Protein | denotes | STAT3 |
| T2255 | 638-642 | Protein | denotes | MGMT |
| T2254 | 532-537 | Protein | denotes | IFN-β |
| T2253 | 518-530 | Protein | denotes | Interferon-β |
| T2252 | 46-50 | Protein | denotes | MGMT |
| T2270 | 1381-1389 | Gene_expression | denotes | positive |
| T2269 | 823-832 | Negative_regulation | denotes | inhibitor |
| T2268 | 842-851 | Negative_regulation | denotes | knockdown |
| T2267 | 598-606 | Positive_regulation | denotes | increase |
| R1528 | T2253 | T2267 | themeOf | Interferon-β,increase |
| R1531 | T2256 | T2269 | themeOf | STAT3,inhibitor |
| R1535 | T2256 | T2268 | themeOf | STAT3,knockdown |
| R1536 | T2257 | T2268 | themeOf | STAT3,knockdown |
| R1539 | T2258 | T2270 | themeOf | CD133,positive |
BioNLP16_DUT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2138 | 1412-1421 | Gene_expression | denotes | expressed |
| T2137 | 1381-1389 | Gene_expression | denotes | positive |
| T2136 | 823-832 | Negative_regulation | denotes | inhibitor |
| T2135 | 842-851 | Negative_regulation | denotes | knockdown |
| T2134 | 598-606 | Positive_regulation | denotes | increase |
| T2125 | 1523-1528 | Protein | denotes | CD133 |
| T2124 | 1375-1380 | Protein | denotes | CD133 |
| T2123 | 836-841 | Protein | denotes | STAT3 |
| T2122 | 817-822 | Protein | denotes | STAT3 |
| T2121 | 638-642 | Protein | denotes | MGMT |
| T2120 | 532-537 | Protein | denotes | IFN-β |
| T2119 | 518-530 | Protein | denotes | Interferon-β |
| T2118 | 46-50 | Protein | denotes | MGMT |
| R1482 | T2119 | T2134 | themeOf | Interferon-β,increase |
| R1483 | T2122 | T2136 | themeOf | STAT3,inhibitor |
| R1484 | T2122 | T2135 | themeOf | STAT3,knockdown |
| R1485 | T2123 | T2135 | themeOf | STAT3,knockdown |
| R1486 | T2124 | T2137 | themeOf | CD133,positive |
| R1487 | T2124 | T2138 | themeOf | CD133,expressed |
bionlp-st-ge-2016-uniprot
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2155 | 638-642 | http://www.uniprot.org/uniprot/P16455 | denotes | MGMT |
| T2154 | 46-50 | http://www.uniprot.org/uniprot/P16455 | denotes | MGMT |
| T2141 | 836-841 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T2140 | 817-822 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
bionlp-st-ge-2016-test-proteins
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1966 | 1523-1528 | Protein | denotes | CD133 |
| T1965 | 1375-1380 | Protein | denotes | CD133 |
| T1964 | 836-841 | Protein | denotes | STAT3 |
| T1963 | 817-822 | Protein | denotes | STAT3 |
| T1962 | 638-642 | Protein | denotes | MGMT |
| T1961 | 532-537 | Protein | denotes | IFN-β |
| T1960 | 518-530 | Protein | denotes | Interferon-β |
| T1959 | 46-50 | Protein | denotes | MGMT |
pmc-enju-pas
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1896 | 1620-1631 | VB | denotes | established |
| T1895 | 1617-1619 | VB | denotes | be |
| T1894 | 1614-1616 | TO | denotes | to |
| T1893 | 1610-1613 | RB | denotes | yet |
| T1892 | 1606-1609 | VB | denotes | has |
| T1891 | 1597-1605 | NN | denotes | function |
| T1890 | 1586-1596 | JJ | denotes | biological |
| T1889 | 1582-1585 | PRP-DOLLAR- | denotes | its |
| T1888 | 1579-1581 | TO | denotes | to |
| T1887 | 1570-1578 | JJ | denotes | relative |
| T1886 | 1564-1569 | NN | denotes | cells |
| T1885 | 1559-1563 | NN | denotes | stem |
| T1884 | 1552-1558 | NN | denotes | cancer |
| T1883 | 1545-1551 | NN | denotes | glioma |
| T1882 | 1541-1544 | IN | denotes | for |
| T1881 | 1534-1540 | NN | denotes | marker |
| T1880 | 1532-1533 | DT | denotes | a |
| T1879 | 1529-1531 | IN | denotes | as |
| T1878 | 1523-1528 | NN | denotes | CD133 |
| T1877 | 1520-1522 | IN | denotes | of |
| T1876 | 1515-1519 | NN | denotes | role |
| T1875 | 1511-1514 | DT | denotes | the |
| T1874 | 1509-1510 | -COMMA- | denotes | , |
| T1873 | 1502-1509 | RB | denotes | However |
| T1872 | 1499-1500 | -RRB- | denotes | ) |
| T1871 | 1495-1499 | CD | denotes | 2012 |
| T1870 | 1493-1494 | -COMMA- | denotes | , |
| T1869 | 1483-1493 | NNP | denotes | Pilkington |
| T1868 | 1479-1482 | CC | denotes | and |
| T1867 | 1471-1478 | NNP | denotes | Donovan |
| T1866 | 1470-1471 | -LRB- | denotes | ( |
| T1865 | 1464-1469 | NN | denotes | cells |
| T1864 | 1459-1463 | NN | denotes | stem |
| T1863 | 1452-1458 | NN | denotes | cancer |
| T1862 | 1448-1451 | CC | denotes | and |
| T1861 | 1442-1447 | NN | denotes | cells |
| T1860 | 1437-1441 | NN | denotes | stem |
| T1859 | 1430-1436 | JJ | denotes | normal |
| T1858 | 1425-1429 | CC | denotes | both |
| T1857 | 1422-1424 | IN | denotes | in |
| T1856 | 1412-1421 | VB | denotes | expressed |
| T1855 | 1408-1411 | VB | denotes | are |
| T1854 | 1402-1407 | NN | denotes | cells |
| T1853 | 1397-1401 | NN | denotes | stem |
| T1852 | 1390-1396 | NN | denotes | cancer |
| T1851 | 1375-1389 | JJ | denotes | CD133-positive |
| T1850 | 1372-1373 | -RRB- | denotes | ) |
| T1849 | 1368-1372 | CD | denotes | 2012 |
| T1848 | 1366-1367 | -COMMA- | denotes | , |
| T1847 | 1363-1366 | FW | denotes | al. |
| T1846 | 1360-1362 | FW | denotes | et |
| T1845 | 1355-1359 | NNP | denotes | Chen |
| T1844 | 1353-1354 | -COLON- | denotes | ; |
| T1843 | 1349-1353 | CD | denotes | 2011 |
| T1842 | 1347-1348 | -COMMA- | denotes | , |
| T1841 | 1344-1347 | FW | denotes | al. |
| T1840 | 1341-1343 | FW | denotes | et |
| T1839 | 1335-1340 | NNP | denotes | Beier |
| T1838 | 1334-1335 | -LRB- | denotes | ( |
| T1837 | 1326-1333 | VB | denotes | thought |
| T1836 | 1315-1325 | RB | denotes | previously |
| T1835 | 1310-1314 | IN | denotes | than |
| T1834 | 1298-1309 | VB | denotes | complicated |
| T1833 | 1293-1297 | RB | denotes | more |
| T1832 | 1288-1292 | VB | denotes | been |
| T1831 | 1284-1287 | VB | denotes | has |
| T1830 | 1278-1283 | NN | denotes | drugs |
| T1829 | 1261-1277 | JJ | denotes | chemotherapeutic |
| T1828 | 1255-1260 | JJ | denotes | other |
| T1827 | 1251-1254 | CC | denotes | and |
| T1826 | 1247-1250 | NN | denotes | TMZ |
| T1825 | 1242-1246 | IN | denotes | with |
| T1824 | 1232-1241 | NN | denotes | treatment |
| T1823 | 1227-1231 | IN | denotes | from |
| T1822 | 1218-1226 | NN | denotes | survival |
| T1821 | 1213-1217 | NN | denotes | cell |
| T1820 | 1208-1212 | NN | denotes | stem |
| T1819 | 1201-1207 | NN | denotes | cancer |
| T1818 | 1198-1200 | IN | denotes | of |
| T1817 | 1190-1197 | NN | denotes | concept |
| T1816 | 1186-1189 | DT | denotes | The |
| T1815 | 1175-1184 | NN | denotes | treatment |
| T1814 | 1171-1174 | NN | denotes | TMZ |
| T1813 | 1168-1170 | IN | denotes | in |
| T1812 | 1160-1167 | NN | denotes | failure |
| T1811 | 1157-1159 | TO | denotes | to |
| T1810 | 1153-1156 | NN | denotes | key |
| T1809 | 1149-1152 | DT | denotes | the |
| T1808 | 1140-1148 | RB | denotes | probably |
| T1807 | 1136-1139 | VB | denotes | are |
| T1806 | 1130-1135 | NN | denotes | cells |
| T1805 | 1125-1129 | NN | denotes | stem |
| T1804 | 1118-1124 | NN | denotes | Cancer |
| T1803 | 1115-1116 | -RRB- | denotes | ) |
| T1802 | 1111-1115 | CD | denotes | 2012 |
| T1801 | 1109-1110 | -COMMA- | denotes | , |
| T1800 | 1106-1109 | FW | denotes | al. |
| T1799 | 1103-1105 | FW | denotes | et |
| T1798 | 1099-1102 | NNP | denotes | Sun |
| T1797 | 1098-1099 | -LRB- | denotes | ( |
| T1796 | 1093-1097 | NN | denotes | GBMs |
| T1795 | 1090-1092 | IN | denotes | in |
| T1794 | 1079-1089 | NN | denotes | resistance |
| T1793 | 1075-1078 | NN | denotes | TMZ |
| T1792 | 1067-1074 | VB | denotes | reverse |
| T1791 | 1064-1066 | TO | denotes | to |
| T1790 | 1055-1063 | VB | denotes | utilized |
| T1789 | 1052-1054 | VB | denotes | be |
| T1788 | 1048-1051 | MD | denotes | can |
| T1787 | 1038-1047 | NN | denotes | hyperoxia |
| T1786 | 1030-1037 | VB | denotes | Induced |
| T1785 | 1018-1028 | NN | denotes | resistance |
| T1784 | 1014-1017 | NN | denotes | TMZ |
| T1783 | 1011-1013 | IN | denotes | of |
| T1782 | 999-1010 | NN | denotes | development |
| T1781 | 995-998 | DT | denotes | the |
| T1780 | 990-994 | IN | denotes | with |
| T1779 | 979-989 | VB | denotes | associated |
| T1778 | 976-978 | VB | denotes | be |
| T1777 | 972-975 | MD | denotes | may |
| T1776 | 968-971 | CC | denotes | and |
| T1775 | 963-967 | NN | denotes | GBMs |
| T1774 | 960-962 | IN | denotes | in |
| T1773 | 953-959 | JJ | denotes | common |
| T1772 | 950-952 | VB | denotes | is |
| T1771 | 942-949 | NN | denotes | hypoxia |
| T1770 | 929-941 | JJ | denotes | Intratumoral |
| T1769 | 926-927 | -RRB- | denotes | ) |
| T1768 | 922-926 | CD | denotes | 2012 |
| T1767 | 920-921 | -COMMA- | denotes | , |
| T1766 | 917-920 | FW | denotes | al. |
| T1765 | 914-916 | FW | denotes | et |
| T1764 | 906-913 | NNP | denotes | Kohsaka |
| T1763 | 905-906 | -LRB- | denotes | ( |
| T1762 | 899-904 | NN | denotes | lines |
| T1761 | 894-898 | NN | denotes | cell |
| T1760 | 890-893 | NN | denotes | GBM |
| T1759 | 880-889 | JJ | denotes | resistant |
| T1758 | 877-879 | IN | denotes | in |
| T1757 | 868-876 | NN | denotes | efficacy |
| T1756 | 864-867 | NN | denotes | TMZ |
| T1755 | 852-863 | VB | denotes | potentiates |
| T1754 | 842-851 | NN | denotes | knockdown |
| T1753 | 836-841 | NN | denotes | STAT3 |
| T1752 | 833-835 | CC | denotes | or |
| T1751 | 823-832 | NN | denotes | inhibitor |
| T1750 | 817-822 | NN | denotes | STAT3 |
| T1749 | 814-815 | -RRB- | denotes | ) |
| T1748 | 810-814 | CD | denotes | 2012 |
| T1747 | 808-809 | -COMMA- | denotes | , |
| T1746 | 805-808 | FW | denotes | al. |
| T1745 | 802-804 | FW | denotes | et |
| T1744 | 796-801 | NNP | denotes | Huang |
| T1743 | 795-796 | -LRB- | denotes | ( |
| T1742 | 785-794 | NN | denotes | mechanism |
| T1741 | 769-784 | JJ | denotes | NF-κB-dependent |
| T1740 | 766-768 | DT | denotes | an |
| T1739 | 762-765 | IN | denotes | via |
| T1738 | 751-761 | NN | denotes | resistance |
| T1737 | 747-750 | NN | denotes | TMZ |
| T1736 | 738-746 | VB | denotes | reverses |
| T1735 | 736-737 | -COMMA- | denotes | , |
| T1734 | 726-736 | NN | denotes | polyphenol |
| T1733 | 718-725 | JJ | denotes | natural |
| T1732 | 716-717 | DT | denotes | a |
| T1731 | 714-715 | -COMMA- | denotes | , |
| T1730 | 703-714 | NN | denotes | Resveratrol |
| T1729 | 700-701 | -RRB- | denotes | ) |
| T1728 | 696-700 | CD | denotes | 2012 |
| T1727 | 694-695 | -COMMA- | denotes | , |
| T1726 | 691-694 | FW | denotes | al. |
| T1725 | 688-690 | FW | denotes | et |
| T1724 | 681-687 | NNP | denotes | Nakada |
| T1723 | 680-681 | -LRB- | denotes | ( |
| T1722 | 669-679 | NN | denotes | mechanisms |
| T1721 | 656-668 | JJ | denotes | -independent |
| T1720 | 653-655 | CC | denotes | or |
| T1719 | 638-652 | JJ | denotes | MGMT-dependent |
| T1718 | 630-637 | IN | denotes | through |
| T1717 | 626-629 | NN | denotes | TMZ |
| T1716 | 623-625 | IN | denotes | of |
| T1715 | 611-622 | NN | denotes | sensitivity |
| T1714 | 607-610 | DT | denotes | the |
| T1713 | 598-606 | VB | denotes | increase |
| T1712 | 596-597 | -RRB- | denotes | ) |
| T1711 | 593-596 | NN | denotes | VAP |
| T1710 | 592-593 | -LRB- | denotes | ( |
| T1709 | 587-591 | NN | denotes | acid |
| T1708 | 578-586 | JJ | denotes | valproic |
| T1707 | 574-577 | CC | denotes | and |
| T1706 | 572-573 | -COMMA- | denotes | , |
| T1705 | 561-572 | NN | denotes | resveratrol |
| T1704 | 559-560 | -COMMA- | denotes | , |
| T1703 | 558-559 | -RRB- | denotes | ) |
| T1702 | 555-558 | NN | denotes | LEV |
| T1701 | 554-555 | -LRB- | denotes | ( |
| T1700 | 540-553 | NN | denotes | levetiracetam |
| T1699 | 538-539 | -COMMA- | denotes | , |
| T1698 | 537-538 | -RRB- | denotes | ) |
| T1697 | 532-537 | NN | denotes | IFN-β |
| T1696 | 531-532 | -LRB- | denotes | ( |
| T1695 | 518-530 | NN | denotes | Interferon-β |
| T1694 | 515-516 | -RRB- | denotes | ) |
| T1693 | 511-515 | CD | denotes | 2011 |
| T1692 | 509-510 | -COMMA- | denotes | , |
| T1691 | 506-509 | FW | denotes | al. |
| T1690 | 503-505 | FW | denotes | et |
| T1689 | 494-502 | NNP | denotes | Goellner |
| T1688 | 493-494 | -LRB- | denotes | ( |
| T1687 | 489-492 | NN | denotes | GBM |
| T1686 | 479-488 | JJ | denotes | recurrent |
| T1685 | 475-478 | CC | denotes | and |
| T1684 | 465-474 | JJ | denotes | resistant |
| T1683 | 460-464 | IN | denotes | with |
| T1682 | 451-459 | NN | denotes | patients |
| T1681 | 448-450 | IN | denotes | in |
| T1680 | 437-447 | NN | denotes | resistance |
| T1679 | 433-436 | NN | denotes | TMZ |
| T1678 | 425-432 | VB | denotes | reverse |
| T1677 | 421-424 | MD | denotes | may |
| T1676 | 408-420 | NN | denotes | biosynthesis |
| T1675 | 406-407 | -RRB- | denotes | ) |
| T1674 | 405-406 | SYM | denotes | + |
| T1673 | 404-405 | -LRB- | denotes | ( |
| T1672 | 401-404 | NN | denotes | NAD |
| T1671 | 397-400 | CC | denotes | and |
| T1670 | 390-396 | NN | denotes | repair |
| T1669 | 381-389 | NN | denotes | excision |
| T1668 | 376-380 | NN | denotes | base |
| T1667 | 373-375 | IN | denotes | of |
| T1666 | 363-372 | NN | denotes | targeting |
| T1665 | 358-362 | JJ | denotes | Dual |
| T1664 | 355-356 | -RRB- | denotes | ) |
| T1663 | 350-355 | NN | denotes | 2012b |
| T1662 | 348-349 | -COMMA- | denotes | , |
| T1661 | 345-348 | FW | denotes | al. |
| T1660 | 342-344 | FW | denotes | et |
| T1659 | 336-341 | NNP | denotes | Zhang |
| T1658 | 334-335 | -COLON- | denotes | ; |
| T1657 | 330-334 | CD | denotes | 2011 |
| T1656 | 328-329 | -COMMA- | denotes | , |
| T1655 | 325-328 | FW | denotes | al. |
| T1654 | 322-324 | FW | denotes | et |
| T1653 | 313-321 | NNP | denotes | Goellner |
| T1652 | 312-313 | -LRB- | denotes | ( |
| T1651 | 302-311 | VB | denotes | tolerated |
| T1650 | 299-301 | CC | denotes | or |
| T1649 | 290-298 | VB | denotes | repaired |
| T1648 | 286-289 | VB | denotes | are |
| T1647 | 278-285 | NN | denotes | adducts |
| T1646 | 261-277 | NN | denotes | O6-methylguanine |
| T1645 | 256-260 | WRB | denotes | when |
| T1644 | 243-255 | RB | denotes | particularly |
| T1643 | 230-242 | NN | denotes | cytotoxicity |
| T1642 | 226-229 | NN | denotes | TMZ |
| T1641 | 223-225 | TO | denotes | to |
| T1640 | 209-222 | RB | denotes | significantly |
| T1639 | 197-208 | VB | denotes | contributes |
| T1638 | 190-196 | NN | denotes | repair |
| T1637 | 181-189 | NN | denotes | excision |
| T1636 | 176-180 | NN | denotes | base |
| T1635 | 173-175 | IN | denotes | of |
| T1634 | 152-172 | NN | denotes | Methoxyamine-blocker |
| T1633 | 149-150 | -RRB- | denotes | ) |
| T1632 | 144-149 | NN | denotes | 2012b |
| T1631 | 142-143 | -COMMA- | denotes | , |
| T1630 | 139-142 | FW | denotes | al. |
| T1629 | 136-138 | FW | denotes | et |
| T1628 | 130-135 | NNP | denotes | Zhang |
| T1627 | 129-130 | -LRB- | denotes | ( |
| T1626 | 125-128 | NN | denotes | TMZ |
| T1625 | 122-124 | TO | denotes | to |
| T1624 | 115-121 | NN | denotes | tumors |
| T1623 | 105-114 | VB | denotes | sensitize |
| T1622 | 102-104 | TO | denotes | to |
| T1621 | 90-101 | NN | denotes | lomeguatrib |
| T1620 | 86-89 | CC | denotes | and |
| T1619 | 69-85 | NN | denotes | O6-benzylguanine |
| T1618 | 67-68 | -COMMA- | denotes | , |
| T1617 | 51-67 | NN | denotes | pseudosubstrates |
| T1616 | 46-50 | NN | denotes | MGMT |
| T1615 | 43-45 | IN | denotes | by |
| T1614 | 34-42 | VB | denotes | achieved |
| T1613 | 31-33 | VB | denotes | be |
| T1612 | 27-30 | MD | denotes | may |
| T1611 | 16-26 | NN | denotes | resistance |
| T1610 | 12-15 | NN | denotes | TMZ |
| T1609 | 9-11 | IN | denotes | of |
| T1608 | 0-8 | NN | denotes | Reversal |
| R1378 | T1834 | T1835 | arg1Of | complicated,than |
| R1155 | T1608 | T1609 | arg1Of | Reversal,of |
| R1156 | T1608 | T1612 | arg1Of | Reversal,may |
| R1157 | T1608 | T1613 | arg1Of | Reversal,be |
| R1158 | T1608 | T1614 | arg2Of | Reversal,achieved |
| R1159 | T1611 | T1609 | arg2Of | resistance,of |
| R1160 | T1611 | T1610 | arg1Of | resistance,TMZ |
| R1161 | T1614 | T1612 | arg2Of | achieved,may |
| R1162 | T1614 | T1613 | arg2Of | achieved,be |
| R1163 | T1617 | T1614 | arg1Of | pseudosubstrates,achieved |
| R1164 | T1617 | T1615 | arg2Of | pseudosubstrates,by |
| R1165 | T1617 | T1616 | arg1Of | pseudosubstrates,MGMT |
| R1166 | T1617 | T1618 | arg1Of | pseudosubstrates,"," |
| R1167 | T1619 | T1620 | arg1Of | O6-benzylguanine,and |
| R1168 | T1620 | T1618 | arg2Of | and,"," |
| R1169 | T1620 | T1622 | modOf | and,to |
| R1170 | T1621 | T1620 | arg2Of | lomeguatrib,and |
| R1171 | T1623 | T1622 | arg1Of | sensitize,to |
| R1172 | T1624 | T1623 | arg2Of | tumors,sensitize |
| R1173 | T1624 | T1625 | arg1Of | tumors,to |
| R1174 | T1626 | T1625 | arg2Of | TMZ,to |
| R1175 | T1626 | T1627 | arg1Of | TMZ,( |
| R1176 | T1628 | T1627 | arg2Of | Zhang,( |
| R1177 | T1628 | T1629 | arg1Of | Zhang,et |
| R1178 | T1628 | T1630 | arg1Of | Zhang,al. |
| R1179 | T1628 | T1631 | arg1Of | Zhang,"," |
| R1180 | T1632 | T1631 | arg2Of | 2012b,"," |
| R1181 | T1633 | T1627 | arg3Of | ),( |
| R1182 | T1634 | T1635 | arg1Of | Methoxyamine-blocker,of |
| R1183 | T1634 | T1639 | arg1Of | Methoxyamine-blocker,contributes |
| R1184 | T1638 | T1635 | arg2Of | repair,of |
| R1185 | T1638 | T1636 | arg1Of | repair,base |
| R1186 | T1638 | T1637 | arg1Of | repair,excision |
| R1187 | T1639 | T1640 | arg1Of | contributes,significantly |
| R1188 | T1639 | T1641 | arg1Of | contributes,to |
| R1189 | T1639 | T1645 | arg1Of | contributes,when |
| R1190 | T1643 | T1641 | arg2Of | cytotoxicity,to |
| R1191 | T1643 | T1642 | arg1Of | cytotoxicity,TMZ |
| R1192 | T1645 | T1644 | arg1Of | when,particularly |
| R1193 | T1647 | T1646 | arg1Of | adducts,O6-methylguanine |
| R1194 | T1647 | T1648 | arg1Of | adducts,are |
| R1195 | T1647 | T1649 | arg2Of | adducts,repaired |
| R1196 | T1647 | T1651 | arg2Of | adducts,tolerated |
| R1197 | T1649 | T1650 | arg1Of | repaired,or |
| R1198 | T1650 | T1645 | arg2Of | or,when |
| R1199 | T1650 | T1648 | arg2Of | or,are |
| R1200 | T1650 | T1652 | arg1Of | or,( |
| R1201 | T1651 | T1650 | arg2Of | tolerated,or |
| R1202 | T1653 | T1652 | arg2Of | Goellner,( |
| R1203 | T1653 | T1654 | arg1Of | Goellner,et |
| R1204 | T1653 | T1655 | arg1Of | Goellner,al. |
| R1205 | T1653 | T1656 | arg1Of | Goellner,"," |
| R1206 | T1653 | T1658 | arg1Of | Goellner,; |
| R1207 | T1657 | T1656 | arg2Of | 2011,"," |
| R1208 | T1659 | T1658 | arg2Of | Zhang,; |
| R1209 | T1659 | T1660 | arg1Of | Zhang,et |
| R1210 | T1659 | T1661 | arg1Of | Zhang,al. |
| R1211 | T1659 | T1662 | arg1Of | Zhang,"," |
| R1212 | T1663 | T1662 | arg2Of | 2012b,"," |
| R1213 | T1664 | T1652 | arg3Of | ),( |
| R1214 | T1666 | T1665 | arg1Of | targeting,Dual |
| R1215 | T1666 | T1667 | arg1Of | targeting,of |
| R1216 | T1670 | T1668 | arg1Of | repair,base |
| R1217 | T1670 | T1669 | arg1Of | repair,excision |
| R1218 | T1670 | T1671 | arg1Of | repair,and |
| R1219 | T1671 | T1667 | arg2Of | and,of |
| R1220 | T1672 | T1671 | arg2Of | NAD,and |
| R1221 | T1672 | T1673 | arg1Of | NAD,( |
| R1222 | T1674 | T1673 | arg2Of | +,( |
| R1223 | T1675 | T1673 | arg3Of | ),( |
| R1224 | T1676 | T1666 | arg1Of | biosynthesis,targeting |
| R1225 | T1676 | T1677 | arg1Of | biosynthesis,may |
| R1226 | T1676 | T1678 | arg1Of | biosynthesis,reverse |
| R1227 | T1678 | T1677 | arg2Of | reverse,may |
| R1228 | T1680 | T1678 | arg2Of | resistance,reverse |
| R1229 | T1680 | T1679 | arg1Of | resistance,TMZ |
| R1230 | T1680 | T1681 | arg1Of | resistance,in |
| R1231 | T1680 | T1683 | arg1Of | resistance,with |
| R1232 | T1682 | T1681 | arg2Of | patients,in |
| R1233 | T1684 | T1685 | arg1Of | resistant,and |
| R1234 | T1686 | T1685 | arg2Of | recurrent,and |
| R1235 | T1687 | T1683 | arg2Of | GBM,with |
| R1236 | T1687 | T1684 | arg1Of | GBM,resistant |
| R1237 | T1687 | T1686 | arg1Of | GBM,recurrent |
| R1238 | T1687 | T1688 | arg1Of | GBM,( |
| R1239 | T1689 | T1688 | arg2Of | Goellner,( |
| R1240 | T1689 | T1690 | arg1Of | Goellner,et |
| R1241 | T1689 | T1691 | arg1Of | Goellner,al. |
| R1242 | T1689 | T1692 | arg1Of | Goellner,"," |
| R1243 | T1693 | T1692 | arg2Of | 2011,"," |
| R1244 | T1694 | T1688 | arg3Of | ),( |
| R1245 | T1695 | T1696 | arg1Of | Interferon-β,( |
| R1246 | T1695 | T1699 | arg1Of | Interferon-β,"," |
| R1247 | T1697 | T1696 | arg2Of | IFN-β,( |
| R1248 | T1698 | T1696 | arg3Of | ),( |
| R1249 | T1699 | T1704 | arg1Of | ",","," |
| R1250 | T1700 | T1699 | arg2Of | levetiracetam,"," |
| R1251 | T1700 | T1701 | arg1Of | levetiracetam,( |
| R1252 | T1702 | T1701 | arg2Of | LEV,( |
| R1253 | T1703 | T1701 | arg3Of | ),( |
| R1254 | T1704 | T1707 | arg1Of | ",",and |
| R1255 | T1705 | T1704 | arg2Of | resveratrol,"," |
| R1256 | T1707 | T1706 | arg1Of | and,"," |
| R1257 | T1707 | T1713 | arg1Of | and,increase |
| R1258 | T1709 | T1707 | arg2Of | acid,and |
| R1259 | T1709 | T1708 | arg1Of | acid,valproic |
| R1260 | T1709 | T1710 | arg1Of | acid,( |
| R1261 | T1711 | T1710 | arg2Of | VAP,( |
| R1262 | T1712 | T1710 | arg3Of | ),( |
| R1263 | T1713 | T1718 | arg1Of | increase,through |
| R1264 | T1713 | T1723 | arg1Of | increase,( |
| R1265 | T1715 | T1713 | arg2Of | sensitivity,increase |
| R1266 | T1715 | T1714 | arg1Of | sensitivity,the |
| R1267 | T1715 | T1716 | arg1Of | sensitivity,of |
| R1268 | T1717 | T1716 | arg2Of | TMZ,of |
| R1269 | T1719 | T1720 | arg1Of | MGMT-dependent,or |
| R1270 | T1721 | T1720 | arg2Of | -independent,or |
| R1271 | T1722 | T1718 | arg2Of | mechanisms,through |
| R1272 | T1722 | T1719 | arg1Of | mechanisms,MGMT-dependent |
| R1273 | T1722 | T1721 | arg1Of | mechanisms,-independent |
| R1274 | T1724 | T1723 | arg2Of | Nakada,( |
| R1275 | T1724 | T1725 | arg1Of | Nakada,et |
| R1276 | T1724 | T1726 | arg1Of | Nakada,al. |
| R1277 | T1724 | T1727 | arg1Of | Nakada,"," |
| R1278 | T1728 | T1727 | arg2Of | 2012,"," |
| R1279 | T1729 | T1723 | arg3Of | ),( |
| R1280 | T1730 | T1731 | arg1Of | Resveratrol,"," |
| R1281 | T1730 | T1736 | arg1Of | Resveratrol,reverses |
| R1282 | T1734 | T1731 | arg2Of | polyphenol,"," |
| R1283 | T1734 | T1732 | arg1Of | polyphenol,a |
| R1284 | T1734 | T1733 | arg1Of | polyphenol,natural |
| R1285 | T1736 | T1735 | arg1Of | reverses,"," |
| R1286 | T1736 | T1739 | arg1Of | reverses,via |
| R1287 | T1736 | T1743 | arg1Of | reverses,( |
| R1288 | T1738 | T1736 | arg2Of | resistance,reverses |
| R1289 | T1738 | T1737 | arg1Of | resistance,TMZ |
| R1290 | T1742 | T1739 | arg2Of | mechanism,via |
| R1291 | T1742 | T1740 | arg1Of | mechanism,an |
| R1292 | T1742 | T1741 | arg1Of | mechanism,NF-κB-dependent |
| R1293 | T1744 | T1743 | arg2Of | Huang,( |
| R1294 | T1744 | T1745 | arg1Of | Huang,et |
| R1295 | T1744 | T1746 | arg1Of | Huang,al. |
| R1296 | T1744 | T1747 | arg1Of | Huang,"," |
| R1297 | T1748 | T1747 | arg2Of | 2012,"," |
| R1298 | T1749 | T1743 | arg3Of | ),( |
| R1299 | T1751 | T1750 | arg1Of | inhibitor,STAT3 |
| R1300 | T1751 | T1752 | arg1Of | inhibitor,or |
| R1301 | T1752 | T1755 | arg1Of | or,potentiates |
| R1302 | T1754 | T1752 | arg2Of | knockdown,or |
| R1303 | T1754 | T1753 | arg1Of | knockdown,STAT3 |
| R1304 | T1757 | T1755 | arg2Of | efficacy,potentiates |
| R1305 | T1757 | T1756 | arg1Of | efficacy,TMZ |
| R1306 | T1757 | T1758 | arg1Of | efficacy,in |
| R1307 | T1762 | T1758 | arg2Of | lines,in |
| R1308 | T1785 | T1783 | arg2Of | resistance,of |
| R1309 | T1785 | T1784 | arg1Of | resistance,TMZ |
| R1310 | T1787 | T1786 | arg2Of | hyperoxia,Induced |
| R1311 | T1787 | T1788 | arg1Of | hyperoxia,can |
| R1312 | T1787 | T1789 | arg1Of | hyperoxia,be |
| R1313 | T1787 | T1790 | arg2Of | hyperoxia,utilized |
| R1314 | T1762 | T1759 | arg1Of | lines,resistant |
| R1315 | T1762 | T1760 | arg1Of | lines,GBM |
| R1316 | T1790 | T1788 | arg2Of | utilized,can |
| R1317 | T1790 | T1789 | arg2Of | utilized,be |
| R1318 | T1762 | T1761 | arg1Of | lines,cell |
| R1319 | T1762 | T1763 | arg1Of | lines,( |
| R1320 | T1792 | T1790 | arg3Of | reverse,utilized |
| R1321 | T1792 | T1791 | arg1Of | reverse,to |
| R1322 | T1764 | T1763 | arg2Of | Kohsaka,( |
| R1323 | T1794 | T1792 | arg2Of | resistance,reverse |
| R1324 | T1794 | T1793 | arg1Of | resistance,TMZ |
| R1325 | T1794 | T1795 | arg1Of | resistance,in |
| R1326 | T1796 | T1795 | arg2Of | GBMs,in |
| R1327 | T1796 | T1797 | arg1Of | GBMs,( |
| R1328 | T1764 | T1765 | arg1Of | Kohsaka,et |
| R1329 | T1798 | T1797 | arg2Of | Sun,( |
| R1330 | T1798 | T1799 | arg1Of | Sun,et |
| R1331 | T1798 | T1800 | arg1Of | Sun,al. |
| R1332 | T1798 | T1801 | arg1Of | Sun,"," |
| R1333 | T1764 | T1766 | arg1Of | Kohsaka,al. |
| R1334 | T1764 | T1767 | arg1Of | Kohsaka,"," |
| R1335 | T1768 | T1767 | arg2Of | 2012,"," |
| R1336 | T1802 | T1801 | arg2Of | 2012,"," |
| R1337 | T1803 | T1797 | arg3Of | ),( |
| R1338 | T1806 | T1804 | arg1Of | cells,Cancer |
| R1339 | T1806 | T1805 | arg1Of | cells,stem |
| R1340 | T1806 | T1807 | arg1Of | cells,are |
| R1341 | T1807 | T1808 | arg1Of | are,probably |
| R1342 | T1769 | T1763 | arg3Of | ),( |
| R1343 | T1810 | T1807 | arg2Of | key,are |
| R1344 | T1810 | T1809 | arg1Of | key,the |
| R1345 | T1810 | T1811 | arg1Of | key,to |
| R1346 | T1810 | T1813 | arg1Of | key,in |
| R1347 | T1771 | T1770 | arg1Of | hypoxia,Intratumoral |
| R1348 | T1812 | T1811 | arg2Of | failure,to |
| R1349 | T1815 | T1813 | arg2Of | treatment,in |
| R1350 | T1815 | T1814 | arg1Of | treatment,TMZ |
| R1351 | T1817 | T1816 | arg1Of | concept,The |
| R1352 | T1817 | T1818 | arg1Of | concept,of |
| R1353 | T1817 | T1823 | arg1Of | concept,from |
| R1354 | T1817 | T1831 | arg1Of | concept,has |
| R1355 | T1817 | T1832 | arg1Of | concept,been |
| R1356 | T1817 | T1834 | arg2Of | concept,complicated |
| R1357 | T1817 | T1837 | arg2Of | concept,thought |
| R1358 | T1771 | T1772 | arg1Of | hypoxia,is |
| R1359 | T1771 | T1773 | arg1Of | hypoxia,common |
| R1360 | T1771 | T1777 | arg1Of | hypoxia,may |
| R1361 | T1771 | T1778 | arg1Of | hypoxia,be |
| R1362 | T1771 | T1779 | arg2Of | hypoxia,associated |
| R1363 | T1822 | T1818 | arg2Of | survival,of |
| R1364 | T1822 | T1819 | arg1Of | survival,cancer |
| R1365 | T1822 | T1820 | arg1Of | survival,stem |
| R1366 | T1822 | T1821 | arg1Of | survival,cell |
| R1367 | T1772 | T1774 | arg1Of | is,in |
| R1368 | T1824 | T1823 | arg2Of | treatment,from |
| R1369 | T1824 | T1825 | arg1Of | treatment,with |
| R1370 | T1826 | T1827 | arg1Of | TMZ,and |
| R1371 | T1772 | T1776 | arg1Of | is,and |
| R1372 | T1827 | T1825 | arg2Of | and,with |
| R1373 | T1773 | T1772 | arg2Of | common,is |
| R1374 | T1830 | T1827 | arg2Of | drugs,and |
| R1375 | T1830 | T1828 | arg1Of | drugs,other |
| R1376 | T1830 | T1829 | arg1Of | drugs,chemotherapeutic |
| R1377 | T1775 | T1774 | arg2Of | GBMs,in |
| R1379 | T1835 | T1831 | arg2Of | than,has |
| R1380 | T1835 | T1832 | arg2Of | than,been |
| R1381 | T1835 | T1833 | arg1Of | than,more |
| R1382 | T1779 | T1776 | arg2Of | associated,and |
| R1383 | T1837 | T1835 | arg2Of | thought,than |
| R1384 | T1837 | T1836 | arg1Of | thought,previously |
| R1385 | T1837 | T1838 | arg1Of | thought,( |
| R1386 | T1839 | T1838 | arg2Of | Beier,( |
| R1387 | T1839 | T1840 | arg1Of | Beier,et |
| R1388 | T1839 | T1841 | arg1Of | Beier,al. |
| R1389 | T1839 | T1842 | arg1Of | Beier,"," |
| R1390 | T1839 | T1844 | arg1Of | Beier,; |
| R1391 | T1843 | T1842 | arg2Of | 2011,"," |
| R1392 | T1779 | T1777 | arg2Of | associated,may |
| R1393 | T1779 | T1778 | arg2Of | associated,be |
| R1394 | T1845 | T1844 | arg2Of | Chen,; |
| R1395 | T1779 | T1780 | arg1Of | associated,with |
| R1396 | T1782 | T1780 | arg2Of | development,with |
| R1397 | T1845 | T1846 | arg1Of | Chen,et |
| R1398 | T1845 | T1847 | arg1Of | Chen,al. |
| R1399 | T1845 | T1848 | arg1Of | Chen,"," |
| R1400 | T1849 | T1848 | arg2Of | 2012,"," |
| R1401 | T1850 | T1838 | arg3Of | ),( |
| R1402 | T1782 | T1781 | arg1Of | development,the |
| R1403 | T1854 | T1851 | arg1Of | cells,CD133-positive |
| R1404 | T1854 | T1852 | arg1Of | cells,cancer |
| R1405 | T1854 | T1853 | arg1Of | cells,stem |
| R1406 | T1854 | T1855 | arg1Of | cells,are |
| R1407 | T1854 | T1856 | arg2Of | cells,expressed |
| R1408 | T1856 | T1855 | arg2Of | expressed,are |
| R1409 | T1856 | T1857 | arg1Of | expressed,in |
| R1410 | T1856 | T1866 | arg1Of | expressed,( |
| R1411 | T1782 | T1783 | arg1Of | development,of |
| R1412 | T1886 | T1882 | arg2Of | cells,for |
| R1413 | T1861 | T1859 | arg1Of | cells,normal |
| R1414 | T1861 | T1860 | arg1Of | cells,stem |
| R1415 | T1861 | T1862 | arg1Of | cells,and |
| R1416 | T1862 | T1857 | arg2Of | and,in |
| R1417 | T1862 | T1858 | arg1Of | and,both |
| R1418 | T1865 | T1862 | arg2Of | cells,and |
| R1419 | T1865 | T1863 | arg1Of | cells,cancer |
| R1420 | T1865 | T1864 | arg1Of | cells,stem |
| R1421 | T1867 | T1868 | arg1Of | Donovan,and |
| R1422 | T1868 | T1866 | arg2Of | and,( |
| R1423 | T1868 | T1870 | arg1Of | and,"," |
| R1424 | T1869 | T1868 | arg2Of | Pilkington,and |
| R1425 | T1871 | T1870 | arg2Of | 2012,"," |
| R1426 | T1872 | T1866 | arg3Of | ),( |
| R1427 | T1886 | T1883 | arg1Of | cells,glioma |
| R1428 | T1886 | T1884 | arg1Of | cells,cancer |
| R1429 | T1886 | T1885 | arg1Of | cells,stem |
| R1430 | T1886 | T1887 | arg1Of | cells,relative |
| R1431 | T1876 | T1875 | arg1Of | role,the |
| R1432 | T1876 | T1877 | arg1Of | role,of |
| R1433 | T1876 | T1879 | arg1Of | role,as |
| R1434 | T1876 | T1892 | arg1Of | role,has |
| R1435 | T1876 | T1895 | arg1Of | role,be |
| R1436 | T1876 | T1896 | arg2Of | role,established |
| R1437 | T1878 | T1877 | arg2Of | CD133,of |
| R1438 | T1887 | T1888 | arg1Of | relative,to |
| R1439 | T1891 | T1888 | arg2Of | function,to |
| R1440 | T1881 | T1879 | arg2Of | marker,as |
| R1441 | T1881 | T1880 | arg1Of | marker,a |
| R1442 | T1881 | T1882 | arg1Of | marker,for |
| R1443 | T1891 | T1889 | arg1Of | function,its |
| R1444 | T1891 | T1890 | arg1Of | function,biological |
| R1445 | T1892 | T1873 | arg1Of | has,However |
| R1446 | T1892 | T1874 | arg1Of | has,"," |
| R1447 | T1892 | T1893 | arg1Of | has,yet |
| R1448 | T1896 | T1892 | arg2Of | established,has |
| R1449 | T1896 | T1894 | arg1Of | established,to |
| R1453 | T1896 | T1895 | arg2Of | established,be |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23459853-21406402-38778514 | 330-334 | 21406402 | denotes | 2011 |
| 23459853-21406402-38778516 | 511-515 | 21406402 | denotes | 2011 |
| 23459853-22912934-38778517 | 696-700 | 22912934 | denotes | 2012 |
| 23459853-22426504-38778518 | 810-814 | 22426504 | denotes | 2012 |
| 23459853-22532597-38778519 | 922-926 | 22532597 | denotes | 2012 |
| 23459853-22763762-38778520 | 1111-1115 | 22763762 | denotes | 2012 |
| 23459853-21988793-38778521 | 1349-1353 | 21988793 | denotes | 2011 |
| 23459853-22854781-38778522 | 1368-1372 | 22854781 | denotes | 2012 |
| 23459853-23106300-38778523 | 1495-1499 | 23106300 | denotes | 2012 |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2017 | 999-1010 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | development |
| T2016 | 408-420 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | biosynthesis |
| T2015 | 401-420 | http://purl.obolibrary.org/obo/GO_0009435 | denotes | NAD(+) biosynthesis |
| T2014 | 105-114 | http://purl.obolibrary.org/obo/GO_0046960 | denotes | sensitize |
| T2010 | 376-396 | http://purl.obolibrary.org/obo/GO_0006284 | denotes | base excision repair |
| T2009 | 176-196 | http://purl.obolibrary.org/obo/GO_0006284 | denotes | base excision repair |
| T1998 | 638-642 | http://purl.obolibrary.org/obo/GO_0003908 | denotes | MGMT |
| T1997 | 46-50 | http://purl.obolibrary.org/obo/GO_0003908 | denotes | MGMT |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2025 | 638-642 | http://purl.obolibrary.org/obo/GO_0003908 | denotes | MGMT |
| T2024 | 46-50 | http://purl.obolibrary.org/obo/GO_0003908 | denotes | MGMT |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2043 | 1564-1569 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2042 | 1464-1469 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2041 | 1442-1447 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2040 | 1402-1407 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2039 | 1130-1135 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T909 | 1502-1632 | Sentence | denotes | However, the role of CD133 as a marker for glioma cancer stem cells relative to its biological function has yet to be established. |
| T908 | 1375-1501 | Sentence | denotes | CD133-positive cancer stem cells are expressed in both normal stem cells and cancer stem cells (Donovan and Pilkington, 2012). |
| T907 | 1186-1374 | Sentence | denotes | The concept of cancer stem cell survival from treatment with TMZ and other chemotherapeutic drugs has been more complicated than previously thought (Beier et al., 2011; Chen et al., 2012). |
| T906 | 1118-1185 | Sentence | denotes | Cancer stem cells are probably the key to failure in TMZ treatment. |
| T905 | 1030-1117 | Sentence | denotes | Induced hyperoxia can be utilized to reverse TMZ resistance in GBMs (Sun et al., 2012). |
| T904 | 929-1029 | Sentence | denotes | Intratumoral hypoxia is common in GBMs and may be associated with the development of TMZ resistance. |
| T903 | 817-928 | Sentence | denotes | STAT3 inhibitor or STAT3 knockdown potentiates TMZ efficacy in resistant GBM cell lines (Kohsaka et al., 2012). |
| T902 | 703-816 | Sentence | denotes | Resveratrol, a natural polyphenol, reverses TMZ resistance via an NF-κB-dependent mechanism (Huang et al., 2012). |
| T901 | 518-702 | Sentence | denotes | Interferon-β (IFN-β), levetiracetam (LEV), resveratrol, and valproic acid (VAP) increase the sensitivity of TMZ through MGMT-dependent or -independent mechanisms (Nakada et al., 2012). |
| T900 | 358-517 | Sentence | denotes | Dual targeting of base excision repair and NAD(+) biosynthesis may reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). |
| T899 | 152-357 | Sentence | denotes | Methoxyamine-blocker of base excision repair contributes significantly to TMZ cytotoxicity particularly when O6-methylguanine adducts are repaired or tolerated (Goellner et al., 2011; Zhang et al., 2012b). |
| T898 | 0-151 | Sentence | denotes | Reversal of TMZ resistance may be achieved by MGMT pseudosubstrates, O6-benzylguanine and lomeguatrib to sensitize tumors to TMZ (Zhang et al., 2012b). |
| T34 | 0-151 | Sentence | denotes | Reversal of TMZ resistance may be achieved by MGMT pseudosubstrates, O6-benzylguanine and lomeguatrib to sensitize tumors to TMZ (Zhang et al., 2012b). |
| T35 | 152-357 | Sentence | denotes | Methoxyamine-blocker of base excision repair contributes significantly to TMZ cytotoxicity particularly when O6-methylguanine adducts are repaired or tolerated (Goellner et al., 2011; Zhang et al., 2012b). |
| T36 | 358-517 | Sentence | denotes | Dual targeting of base excision repair and NAD(+) biosynthesis may reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). |
| T37 | 518-702 | Sentence | denotes | Interferon-β (IFN-β), levetiracetam (LEV), resveratrol, and valproic acid (VAP) increase the sensitivity of TMZ through MGMT-dependent or -independent mechanisms (Nakada et al., 2012). |
| T38 | 703-816 | Sentence | denotes | Resveratrol, a natural polyphenol, reverses TMZ resistance via an NF-κB-dependent mechanism (Huang et al., 2012). |
| T39 | 817-928 | Sentence | denotes | STAT3 inhibitor or STAT3 knockdown potentiates TMZ efficacy in resistant GBM cell lines (Kohsaka et al., 2012). |
| T40 | 929-1029 | Sentence | denotes | Intratumoral hypoxia is common in GBMs and may be associated with the development of TMZ resistance. |
| T41 | 1030-1117 | Sentence | denotes | Induced hyperoxia can be utilized to reverse TMZ resistance in GBMs (Sun et al., 2012). |
| T42 | 1118-1185 | Sentence | denotes | Cancer stem cells are probably the key to failure in TMZ treatment. |
| T43 | 1186-1374 | Sentence | denotes | The concept of cancer stem cell survival from treatment with TMZ and other chemotherapeutic drugs has been more complicated than previously thought (Beier et al., 2011; Chen et al., 2012). |
| T44 | 1375-1501 | Sentence | denotes | CD133-positive cancer stem cells are expressed in both normal stem cells and cancer stem cells (Donovan and Pilkington, 2012). |
| T45 | 1502-1632 | Sentence | denotes | However, the role of CD133 as a marker for glioma cancer stem cells relative to its biological function has yet to be established. |
simple1
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2073 | 1523-1528 | Protein | denotes | CD133 |
| T2072 | 1375-1380 | Protein | denotes | CD133 |
| T2071 | 836-841 | Protein | denotes | STAT3 |
| T2070 | 817-822 | Protein | denotes | STAT3 |
| T2069 | 638-642 | Protein | denotes | MGMT |
| T2068 | 532-537 | Protein | denotes | IFN-β |
| T2067 | 518-530 | Protein | denotes | Interferon-β |
| T2066 | 46-50 | Protein | denotes | MGMT |